Significance: Wang and co-workers describe a kilogram-scale asymmetric synthesis of intermediate H en route to omarigliptin, a DPP-4 inhibitor that is of interest for the treatment of diabetes. The key steps in the synthesis depicted are (1) the diastereoselective substrate-controlled MeerweinPonndorf-Verley reduction of α-aminoketone C and (2) the stereoselective intramolecular 5-exodig iodoetherification of alkynol E.
Comment: Synthesis of A began with the asymmetric α-alkylation of nickel(II) complex I with 3-chloro-1-propyne. The choice of solvent and temperature was critical to achieve a reproducible conversion and high stereoselectivity for this alkylation. Best results were obtained using sodium hydroxide in DMF at -10 °C. At the end of the reaction, water was added to the reaction mixture, and product J crystallized out from the aqueous media. 
